Editas Medicine (EDIT) Current Assets (2015 - 2025)

Editas Medicine (EDIT) has reported Current Assets for 11 consecutive years, with $163.9 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Current Assets fell 43.35% year-over-year to $163.9 million; the TTM figure through Dec 2025 stood at $163.9 million (down 43.35% YoY), while the FY2025 annual figure was $163.9 million, down 43.35% from the prior year.
• Current Assets declined to $163.9 million in Q4 2025 per EDIT's latest filing, from $176.9 million in the prior quarter.
• Across five years, Current Assets topped out at $632.3 million in Q1 2021 and bottomed at $163.9 million in Q4 2025.
• Historically, Current Assets has averaged $371.5 million across 5 years, with a median of $348.8 million in 2022.
• Annual changes were most pronounced in 2021 — Current Assets jumped 48.74% — and 2025, when it plunged 43.35%.
• Editas Medicine's Current Assets stood at $507.3 million in 2021, then slipped by 29.68% to $356.8 million in 2022, then decreased by 4.46% to $340.8 million in 2023, then declined by 15.11% to $289.3 million in 2024, then slumped by 43.35% to $163.9 million in 2025.
• Business Quant data shows EDIT's Current Assets at $163.9 million in Q4 2025, $176.9 million in Q3 2025, and $182.8 million in Q2 2025.